ARTHQ (Arch Therapeutics) Days Payable: 12,790.21 (As of Jun. 2024)


ARTHQ Arch Therapeutics Inc ARTHQ
12 GF Score
Price $0.00
View Full Analysis

What is Arch Therapeutics Days Payable?

Arch Therapeutics ARTHQ -99.00% 12 Days Payable is 12,790.21 as of Jun. 2024. GuruFocus rates ARTHQ with a GF Score™ of 12/100.

Arch Therapeutics's average Accounts Payable for the three months ended in Jun. 2024 was $2.94 Mil. Arch Therapeutics's Cost of Goods Sold for the three months ended in Jun. 2024 was $0.02 Mil. Hence, Arch Therapeutics's Days Payable for the three months ended in Jun. 2024 was 12,790.21.

The historical rank and industry rank for Arch Therapeutics's Days Payable or its related term are showing as below:

ARTHQ's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Arch Therapeutics's Days Payable increased from Jun. 2023 (12,412.53) to Jun. 2024 (12,790.21). It may suggest that Arch Therapeutics delayed paying its suppliers.

Arch Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for Arch Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Therapeutics Days Payable Chart

Arch Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 5,069.44 6,092.69 8,497.95

Arch Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,412.53 9,077.47 9,649.69 11,908.13 12,790.21

ARTHQ vs GRTSQ, MTEM, PXMD: Days Payable Comparison

For the Biotechnology subindustry, Arch Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Arch Therapeutics's Days Payable falls into.


ARTHQ
12GF Score
Arch Therapeutics Inc ARTHQ
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Arch Therapeutics's Days Payable for the fiscal year that ended in Sep. 2023 is calculated as

Days Payable (A: Sep. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Sep. 2022 ) + Accounts Payable (A: Sep. 2023 )) / count ) / Cost of Goods Sold (A: Sep. 2023 )*Days in Period
=( (1.328 + 2.304) / 2 ) / 0.078*365
=1.816 / 0.078*365
=8,497.95

Arch Therapeutics's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2024 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (2.97 + 2.917) / 2 ) / 0.021*365 / 4
=2.9435 / 0.021*365 / 4
=12,790.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 12,790.21 mean?
Arch Therapeutics (ARTHQ) has a Days Payable of 12,790.21 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arch Therapeutics and its competitors.
Is Arch Therapeutics' Days Payable too high?
Arch Therapeutics' current Days Payable is 12,790.21. The Biotechnology industry median Days Payable is 113.56. Arch Therapeutics' value of 12,790.21 is 11163% above this industry median. Overall, Arch Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Arch Therapeutics' Days Payable compare to GRTSQ and MTEM?
Arch Therapeutics' Days Payable of 12,790.21 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.56. Arch Therapeutics' value of 12,790.21 is 11163% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arch Therapeutics's current Days Payable of 12,790.21 is 11163% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arch Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arch Therapeutics's current Days Payable is 12,790.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Therapeutics stock overvalued right now?
Arch Therapeutics (ARTHQ) has a current Days Payable of 12,790.21. The current Days Payable is 12,790.21 and 11163% above the Biotechnology industry median of 113.56. Arch Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Arch Therapeutics (ARTHQ), the current Days Payable is 12,790.21 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Therapeutics Business Description

Address 235 Walnut Street, Suite 6, Framingham, MA, USA, 01702
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
12GF Score

Get the complete analysis for ARTHQ

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price